BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 18668539)

  • 41. NLRP3 inflammasome-mediated neutrophil recruitment and hypernociception depend on leukotriene B(4) in a murine model of gout.
    Amaral FA; Costa VV; Tavares LD; Sachs D; Coelho FM; Fagundes CT; Soriani FM; Silveira TN; Cunha LD; Zamboni DS; Quesniaux V; Peres RS; Cunha TM; Cunha FQ; Ryffel B; Souza DG; Teixeira MM
    Arthritis Rheum; 2012 Feb; 64(2):474-84. PubMed ID: 21952942
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effects of a CXCR1/CXCR2 antagonist on neutrophil migration in mild atopic asthmatic subjects.
    Todd CM; Salter BM; Murphy DM; Watson RM; Howie KJ; Milot J; Sadeh J; Boulet LP; O'Byrne PM; Gauvreau GM
    Pulm Pharmacol Ther; 2016 Dec; 41():34-39. PubMed ID: 27640067
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The role of CXCR1/2 in shear stress-induced endothelial cell migration].
    Sun H; Wei L; Liu X; Zeng Y; Lai Y; Yin H
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2009 Jun; 26(3):512-7. PubMed ID: 19634663
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Receptor binding mode and pharmacological characterization of a potent and selective dual CXCR1/CXCR2 non-competitive allosteric inhibitor.
    Bertini R; Barcelos LS; Beccari AR; Cavalieri B; Moriconi A; Bizzarri C; Di Benedetto P; Di Giacinto C; Gloaguen I; Galliera E; Corsi MM; Russo RC; Andrade SP; Cesta MC; Nano G; Aramini A; Cutrin JC; Locati M; Allegretti M; Teixeira MM
    Br J Pharmacol; 2012 Jan; 165(2):436-54. PubMed ID: 21718305
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The combined CXCR1/CXCR2 antagonist CXCL8(3-74)K11R/G31P blocks neutrophil infiltration, pyrexia, and pulmonary vascular pathology in endotoxemic animals.
    Gordon JR; Li F; Zhang X; Wang W; Zhao X; Nayyar A
    J Leukoc Biol; 2005 Dec; 78(6):1265-72. PubMed ID: 16204619
    [TBL] [Abstract][Full Text] [Related]  

  • 46. LPS challenge in healthy subjects: an investigation of neutrophil chemotaxis mechanisms involving CXCR1 and CXCR2.
    Aul R; Patel S; Summerhill S; Kilty I; Plumb J; Singh D
    Int Immunopharmacol; 2012 Jul; 13(3):225-31. PubMed ID: 22561413
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mechanisms of the anti-inflammatory actions of the angiotensin type 1 receptor antagonist losartan in experimental models of arthritis.
    Silveira KD; Coelho FM; Vieira AT; Barroso LC; Queiroz-Junior CM; Costa VV; Sousa LF; Oliveira ML; Bader M; Silva TA; Santos RA; Silva AC; Teixeira MM
    Peptides; 2013 Aug; 46():53-63. PubMed ID: 23727291
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The chemokine receptors CXCR1 and CXCR2 regulate oral cancer cell behaviour.
    Khurram SA; Bingle L; McCabe BM; Farthing PM; Whawell SA
    J Oral Pathol Med; 2014 Oct; 43(9):667-74. PubMed ID: 24965032
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Downregulation of CXCR1 and CXCR2 expression on human neutrophils by Helicobacter pylori: a new pathomechanism in H. pylori infection?
    Schmausser B; Josenhans C; Endrich S; Suerbaum S; Sitaru C; Andrulis M; Brändlein S; Rieckmann P; Müller-Hermelink HK; Eck M
    Infect Immun; 2004 Dec; 72(12):6773-9. PubMed ID: 15557597
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Resolution of neutrophilic inflammation by H2O2 in antigen-induced arthritis.
    Lopes F; Coelho FM; Costa VV; Vieira ÉL; Sousa LP; Silva TA; Vieira LQ; Teixeira MM; Pinho V
    Arthritis Rheum; 2011 Sep; 63(9):2651-60. PubMed ID: 21567381
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Metalloproteinases are involved in lipopolysaccharide- and tumor necrosis factor-alpha-mediated regulation of CXCR1 and CXCR2 chemokine receptor expression.
    Khandaker MH; Mitchell G; Xu L; Andrews JD; Singh R; Leung H; Madrenas J; Ferguson SS; Feldman RD; Kelvin DJ
    Blood; 1999 Apr; 93(7):2173-85. PubMed ID: 10090924
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CXCR2 antagonists block the N-Ac-PGP-induced neutrophil influx in the airways of mice, but not the production of the chemokine CXCL1.
    Braber S; Overbeek SA; Koelink PJ; Henricks PA; Zaman GJ; Garssen J; Kraneveld AD; Folkerts G
    Eur J Pharmacol; 2011 Oct; 668(3):443-9. PubMed ID: 21458445
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CXC chemokine receptor 2 but not C-C chemokine receptor 1 expression is essential for neutrophil recruitment to the cornea in helminth-mediated keratitis (river blindness).
    Hall LR; Diaconu E; Patel R; Pearlman E
    J Immunol; 2001 Mar; 166(6):4035-41. PubMed ID: 11238651
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A novel, orally active CXCR1/2 receptor antagonist, Sch527123, inhibits neutrophil recruitment, mucus production, and goblet cell hyperplasia in animal models of pulmonary inflammation.
    Chapman RW; Minnicozzi M; Celly CS; Phillips JE; Kung TT; Hipkin RW; Fan X; Rindgen D; Deno G; Bond R; Gonsiorek W; Billah MM; Fine JS; Hey JA
    J Pharmacol Exp Ther; 2007 Aug; 322(2):486-93. PubMed ID: 17496165
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CXCL8-induced FAK phosphorylation via CXCR1 and CXCR2: cytoskeleton- and integrin-related mechanisms converge with FAK regulatory pathways in a receptor-specific manner.
    Cohen-Hillel E; Yron I; Meshel T; Soria G; Attal H; Ben-Baruch A
    Cytokine; 2006 Jan; 33(1):1-16. PubMed ID: 16406804
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reduction of NETosis by targeting CXCR1/2 reduces thrombosis, lung injury, and mortality in experimental human and murine sepsis.
    Alsabani M; Abrams ST; Cheng Z; Morton B; Lane S; Alosaimi S; Yu W; Wang G; Toh CH
    Br J Anaesth; 2022 Feb; 128(2):283-293. PubMed ID: 34893315
    [TBL] [Abstract][Full Text] [Related]  

  • 57. IL-8-induced migratory responses through CXCR1 and CXCR2: association with phosphorylation and cellular redistribution of focal adhesion kinase.
    Feniger-Barish R; Yron I; Meshel T; Matityahu E; Ben-Baruch A
    Biochemistry; 2003 Mar; 42(10):2874-86. PubMed ID: 12627953
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cell-specific regulatory effects of CXCR2 on cholestatic liver injury.
    Konishi T; Schuster RM; Goetzman HS; Caldwell CC; Lentsch AB
    Am J Physiol Gastrointest Liver Physiol; 2019 Dec; 317(6):G773-G783. PubMed ID: 31604030
    [TBL] [Abstract][Full Text] [Related]  

  • 59. ELR-CXC chemokine receptor antagonism targets inflammatory responses at multiple levels.
    Zhao X; Town JR; Li F; Zhang X; Cockcroft DW; Gordon JR
    J Immunol; 2009 Mar; 182(5):3213-22. PubMed ID: 19234219
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CXCR2 is critical to hyperoxia-induced lung injury.
    Sue RD; Belperio JA; Burdick MD; Murray LA; Xue YY; Dy MC; Kwon JJ; Keane MP; Strieter RM
    J Immunol; 2004 Mar; 172(6):3860-8. PubMed ID: 15004193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.